Activins in Pulmonary Arterial Hypertension: More Than Targets for Treatment?

Tues, Jan. 30, 2024
A panel of experts will discuss will the role of activin signaling in the plasma and lung of pulmonary arterial hypertension. Following the successful development of sotatercept as activin ligand trap, it remains unknown whether activins may serve as biomarkers of disease.